HUTCHMED (China) Limited (H7T1) — Capital Reinvestment Ratio
Latest as of December 2024:
36.08x
HUTCHMED (China) Limited (H7T1) has a Capital Reinvestment Ratio of 36.08x as of December 2024, meaning it reinvests 36% of its operating cash flow (€497.00K) in capital expenditures (€17.93 Million). See HUTCHMED (China) Limited free cash flow efficiency to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
36.08x
Capex / Operating Cash Flow
Operating Cash Flow
€497.00K
EUR
Capital Expenditures
€17.93 Million
EUR
Data as of
Dec 2024
Most recent filing
HUTCHMED (China) Limited Capital Reinvestment Ratio (2023–2024)
This chart tracks HUTCHMED (China) Limited's Capital Reinvestment Ratio across 2 annual periods.
Annual Capital Reinvestment Ratio for HUTCHMED (China) Limited (2023–2024)
Year-by-year Capital Reinvestment Ratio for HUTCHMED (China) Limited from 2023 to 2024. For live market cap and broader valuation context, see how much is HUTCHMED (China) Limited worth.
| Year | Reinvestment Ratio | Operating CF (EUR) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 36.08x | €497.00K | €17.93 Million | ▲ +24159.1% |
| 2023 | 0.15x | €219.26 Million | €32.61 Million | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow